Massimo Gadina
Company: NIAMS/NIH
Job title: Director & Chief of Translational Immunology Section, Science & Technology
Seminars:
Speaker Q&A panel 2:30 pm
day: Day Two
An Overview of JAKi in Rheumotology 2:05 pm
Historical overview of how JAK inhibitors were developed. Review of first-generation pan-JAK inhibitors and their current clinical application JAK-selective, second-generation JAK inhibitors: what is there already and what is arriving. The effect of JAK inhibitors on circulating immune cellRead more
day: Day Two